Evolution of the c-kit-positive cell response to pathological challenge in the myocardium

Stem Cells

Volumn 26, Issue 5, 2008, Pages 1315-1324

  Fransioli, Jenna ^a   Bailey, Brandi ^a   Gude, Natalie A ^a   Cottage, Christopher T ^a   Muraski, John A ^a   Emmanuel, Gregory ^a   Wu, Weitao ^a   Alvarez, Roberto ^a   Rubio, Marta ^a   Ottolenghi, Sergio ^b   Schaefer, Erik ^c   Sussman, Mark A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c INVITROGEN CORPORATION   (United States)

Author keywords

c kit; Cardiac stem cell; Heart; Infarction

Indexed keywords

BIOLOGICAL MARKER; GREEN FLUORESCENT PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL POPULATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HEART INFARCTION; HEART MUSCLE; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PERINATAL PERIOD; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINEAGE; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; METABOLISM; NEWBORN; PATHOLOGY; PROTEIN TRANSPORT; STEM CELL; TIME; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; ENDOTHELIAL CELLS; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; TIME FACTORS;

EID: 47949083823     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0751     Document Type: Article

References (53)

1. Lensch MW, Daheron L, Schlaeger TM. Pluripotent stem cells and their niches. Stem Cell Rev 2006;2:185-202.
2. Jahagirdar BN, Verfaillie CM. Multipotent adult progenitor cell and stem cell plasticity. Stem Cell Rev 2005;1:53-59.
3. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-776.
4. Guan K, Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes? J Mol Cell Cardiol 2007;43:377-387.
5. Bearzi C, Rota M, Hosoda T et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007;104:14068-14073.
6. Broxmeyer HE, Maze R, Miyazawa K et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 1991;3:480-487.
7. Edling CE, Hallberg B. c-Kit - A hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol 2007;39:1995-1998.
8. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993;142:965-974.
9. Mauduit C, Hamamah S, Benahmed M. Stem cell factor/c-kit system in spermatogenesis. Hum Reprod Update 1999;5:535-545.
10. Rossi P, Sette C, Dolci S et al. Role of c-kit in mammalian spermatogenesis. J Endocrinol Invest 2000;23:609-615.
11. Matsui J, Wakabayashi T, Asada M et al. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J Biol Chem 2004;279:18600-18607.
12. Chien KR. Lost and found: Cardiac stem cell therapy revisited. J Clin Invest 2006;116:1838-1840.
13. Fazel S, Angoulvant D, Desai N et al. Cardiac restoration: Frontier or fantasy? Can J Cardiol 2005;21:355-359.
14. Gepstein L. Cardiovascular therapeutic aspects of cell therapy and stem cells. Ann N Y Acad Sci 2006;1080:415-425.
15. Leinwand LA. Hope for a broken heart? Cell 2003;114:658-659.
16. Leri A, Kajstura J, Anversa P. Regenerating the myocardium: A reality today. Can J Cardiol 2005;21:361-362.
17. Orlic D, Kajstura J, Chimenti S et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-10349.
18. Ott HC, Matthiesen TS, Brechtken J et al. The adult human heart as a source for stem cells: Repair strategies with embryonic-like progenitor cells. Nat Clin Pract Cardiovasc Med 2007;4(suppl 1):S27-S39.
19. Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol 2007:195-218.
20. Togel F, Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 2007;236:3321-3331.
21. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668.
22. Loscalzo J. Stem cells and regeneration of the cardiovascular system: Facts, fictions, and uncertainties. Blood Cells Mol Dis 2004;32:97-99.
23. Hsieh PC, Segers VF, Davis ME et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007;13:970-974.
24. Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673.
25. Oh H, Chi X, Bradfute SB et al. Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci 2004;1015:182-189.
26. Cairns LA, Moroni E, Levantini E et al. Kit regulatory elements required for expression in developing hematopoietic and germ cell lineages. Blood 2003;102:3954-3962.
27. Kato T, Muraski J, Chen Y et al. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest 2005;115:2716-2730.
28. Gude N, Muraski J, Rubio M et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 2006;99:381-388.
29. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 2006;20:3347-3365.
30. Rudolph AM. Myocardial growth before and after birth: Clinical implications. Acta Paediatr 2000;89:129-133.
31. David H, Bozner A, Meyer R et al. Pre-and postnatal development and ageing of the heart. Ultrastructural results and quantitative data. Exp Pathol Suppl 1981;7:1-176.
32. Zak R, Kizu A, Bugaisky L. Cardiac hypertrophy: Its characteristics as a growth process. Am J Cardiol 1979;44:941-946.
33. Kafienah W, Mistry S, Williams C et al. Nucleostemin is a marker of proliferating stromal stem cells in adult human bone marrow. STEM CELLS 2006;24:1113-1120.
34. Yaghoobi MM, Mowla SJ, Tiraihi T. Nucleostemin, a coordinator of self-renewal, is expressed in rat marrow stromal cells and turns off after induction of neural differentiation. Neurosci Lett 2005;390:81-86.
35. Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002;16:2991-3003.
36. Coates PJ, Hales SA, Hall PA. The association between cell proliferation and apoptosis: Studies using the cell cycle-associated proteins Ki67 and DNA polymerase alpha. J Pathol 1996;178:71-77.
37. Iatropoulos MJ, Williams GM. Proliferation markers. Exp Toxicol Pathol 1996;48:175-181.
38. Karamboulas C, Dakubo GD, Liu J et al. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis. J Cell Sci 2006;119:4315-4321.
39. Kolodziejczyk SM, Wang L, Balazsi K et al. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 1999;9:1203-1206.
40. Besmer P. The kit ligand encoded at the murine Steel locus: A pleiotropic growth and differentiation factor. Curr Opin Cell Biol 1991;3:939-946.
41. Barile L, Chimenti I, Gaetani R et al. Cardiac stem cells: Isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med 2007;4(suppl 1):S9-S14.
42. Fazel S, Cimini M, Chen L et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877.
43. Fujita J, Mori M, Kawada H et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. STEM CELLS 2007;25:2750-2759.
44. Wang Y, Haider H, Ahmad N et al. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol 2006;41:478-487.
45. Barile L, Messina E, Giacomello A et al. Endogenous cardiac stem cells. Prog Cardiovasc Dis 2007;50:31-48.
46. Jackson KA, Majka SM, Wang H et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-1402.
47. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
48. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10:494-501.
49. Dawn B, Stein AB, Urbanek K et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005;102:3766-3771.
50. Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005;102:8966-8971.
51. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-705.
52. Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005;97:663-673.
53. Zhou R, Acton PD, Ferrari VA. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 2006;48:2094-2106.